Skip to content

Antibody and Blood Markers in Long-Haulers: The Search for Tests that can Predict Development and Severity of Long COVID

COVID-19 | Long COVID | Post-COVID Syndrome

COVID-19 has had a significant impact on the lives of many Albertans. Even in those who recover from acute illness, many go on to suffer from lingering persistent symptoms, known as Long COVID, where currently there is no cure. In this study, we aim to improve understanding of why only some people develop long COVID and why some people develop more severe symptoms than others. To do so, we will look for specific blood and COVID-19 antibody markers in patients post COVID-19. This information will provide an understanding of the mechanisms associated with long COVID, which may reveal factors that contribute to long COVID development. With this knowledge, future treatment may then be possible to target the underlying cause of long COVID.

null

Conditions de participation

  • Sexe:

    Any

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:
Any adult individuals (aged 18 and up) who have recovered from acute COVID-19 (as confirmed by a COVID-19 test) and experiencing persistent symptoms of at least 12 weeks are invited to participate in this study. Adult patients who have recovered from COVID-19 but are not suffering from long COVID symptoms as well as healthy individuals who have never been infected with COVID-19 are also invited to participate as the comparison group in this study.
Exclusion Criteria:
Any individuals not meeting the above criteria

Lieu de l'étude

University of Alberta
University of Alberta
Edmonton, Alberta
Canada

Contactez l'équipe d'étude

Primary Contact

Grace Lam

[email protected]
null
Étude parrainée par
University of Alberta
Participants recherchés
Plus d'informations
ID de l'étude: Pro00105660